Advertisement
Screener

ACER THERAPEUTICS INC. Form D

ACER THERAPEUTICS INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2013-02-19: Federal exemption Rule 506; Types of securities offered OptionToAcquire; SecurityToBeAcquired; Date of first sale 2013-01-29; Total offering amount Indefinite.
  • 2013-02-19: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2013-01-23; Total offering amount $650,000.
  • 2012-07-27: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2012-07-25; Total offering amount $4,085,000.
  • 2009-04-27: Federal exemption Rule 506; Types of securities offered Offering was for Issuer's Units. Each Unit consists of (A) $10,000 convertible note, convertible into 15,000 shs of Issuer's common stock at $0.75 p/share & (B) Series G Warrant to purchase 10,000 shs of Issuer's common stock at $0.50 p/share.; Date of first sale 2009-04-14; Total offering amount $2,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2013-02-19Rule 506OptionToAcquire; SecurityToBeAcquired2013-01-29Indefinite$0Indefinite21
2013-02-19Rule 506Debt; OptionToAcquire; SecurityToBeAcquired2013-01-23$650,000$650,000$05
2012-07-27Rule 506Debt; OptionToAcquire; SecurityToBeAcquired2012-07-25$4,085,000$4,085,000$021
2009-04-27Rule 506Offering was for Issuer's Units. Each Unit consists of (A) $10,000 convertible note, convertible into 15,000 shs of Issuer's common stock at $0.75 p/share & (B) Series G Warrant to purchase 10,000 shs of Issuer's common stock at $0.50 p/share.2009-04-14$2,000,000$1,101,000$899,00028